rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2004-3-17
|
pubmed:abstractText |
Percutaneous ethanol injection (PEI) is an established method in the treatment of hepatocellular carcinoma (HCC) and considered a safe procedure, with severe complications occurring rarely. Cardiac arrhythmias have not been reported to date. Aim of the study was to investigate the occurrence of dysrhythmias during PEI.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2972
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
218-23
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15025681-Bradycardia,
pubmed-meshheading:15025681-Carcinoma, Hepatocellular,
pubmed-meshheading:15025681-Dose-Response Relationship, Drug,
pubmed-meshheading:15025681-Electrocardiography,
pubmed-meshheading:15025681-Ethanol,
pubmed-meshheading:15025681-Heart Block,
pubmed-meshheading:15025681-Humans,
pubmed-meshheading:15025681-Injections, Intralesional,
pubmed-meshheading:15025681-Liver Neoplasms
|
pubmed:year |
2004
|
pubmed:articleTitle |
Bradycardia and sinus arrest during percutaneous ethanol injection therapy for hepatocellular carcinoma.
|
pubmed:affiliation |
University of Vienna Medical School, Vienna, Austria.
|
pubmed:publicationType |
Journal Article
|